Anthralin is a potent topical drug, inducing clearance of psoriatic plaques. Anthralin disrupts mitochondrial function and structure, but its mechanism of action remains undefined. This study aimed to determine whether anthralin induced keratinocyte apoptosis as well as to investigate molecular mechanisms and the role of mitochondria. We studied human keratinocytes and human 143B rho(0) cells, ...

The potentiating effect of tumour promoter anthralin on gamma radiation and 4-Nitroquinoline 1oxide (4-NQO) induced gene conversion and back mutation was studied using diploid yeast Saccharomyces cerevisiae D7. Cells were exposed to 20-400 Gy of gamma radiation and plated on media without anthralin or containing 0.0510 mg/ml of anthralin. In another set of experiments, cells were treated with 0...

One-electron reduction significantly enhances the ability of anthralin, 1, to act as a hydrogen atom donor. On annealing of an MTHF glass in which the radical anion of anthralin, 1*-, is generated radiolytically, this species decays mainly by loss of H* to give the anthralyl anion, 2- . On the other hand, radicals formed on radiolysis of matrices that are suitable for the generation of radical ...

10-bromo-1,8-dihydroxy-9-anthrone (10-bromoanthralin) was synthesized with precise ratio of bromine to anthralin (1.10:1), respectively. With this ratio of the reagents, the reaction is repetitive at any scale. This compound is a highly significant intermediate for the synthesis of many anthralin derivetised antipsoriatic drugs. Bromination at both benzylic and aromatic ring positions of anthra...

The tumor promoter anthralin stimulated prostaglandin E2 (PGE2) and arachidonic acid release from primary cultures of mouse epidermal cells. Epidermal growth factor (EGF) hardly stimulated PGE2 release by itself; however, a combination of anthralin and EGF synergistically stimulated PGE2 release. Neither anthralin, EGF nor EGF plus anthralin affected the incorporation of arachidonic acid into c...

The widely used topical agents anthralin and benzoyl peroxide are potent skin irritants. In the mouse skin model these compounds produce hyperplasia nd are effective skin tumor promoters. In the present studies, we have examined the effects of anthralin and benzoyl peroxide on epidermal proteins and compared them with changes produced by the potent phorbol ester tumor promoter 12-O-tetradecanoy...

Raab & Gmeiner (1975) have published experiments concerning a 'biochemically highly active compound' obtained from anthralin by irradiation. Raab's u.v.-spectra in dimethylformamide ( D M F ) are reproducible and indicate an anthracene species, whilst in methanol the spectrum is of the dihydroxyanthrone (benzophenone) type. The conversion of these two species is reversible and is brought about ...

The retinoids all-trans-retinoic acid, 13-cis-retinoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1E- propen-1-yl]benzoic acid, 6-[1-(4-carboxyphenyl)-1E-propen-2-yl]-3,4-dihydro-4,4-dimethyl-2H -1-benzothiopyran, and 6-(5,6,7,8,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)- 2-naphthalenecarboxylic acid inhibited the induction of ornithine decarboxylase in CD-1 mouse ...

Anthralin and some of its derivatives have implied antipsoriatic effect in clinical and pharmaceutical studies. Anthralin is synthesized by different strategies. In this work we report the synthesis of "OEHA" as a precursor of another biological active compound.

treatment of 10-bromoanthralin (1) with several thiophenols (2) gave the corresponding 10-arylthioanthralins (3) in high yields. oxidation of thioanthralins (3a-c) and (3k-m) using an excess of m-chloroperbenzoic acid gave the corresponding sulfones (4a-c) and (4k-m) in good yields. oxidation of thioanthralins (3d-f) gave a mixture of the corresponding sulfones (4d-f) and anthralin-10,10'-dehyd...